In recent years, noninvasive prenatal screening (NIPS) tests have gained significant traction among expectant parents. These tests, which require only a small sample of blood from the expectant mother, offer a seemingly simple and noninvasive way to assess the risk of chromosomal conditions like Down syndrome and other genetic anomalies in a developing fetus. Many